Literature DB >> 21874376

Budget impact analysis in economic evaluation: a proposal for a clearer definition.

Livio Garattini, Katelijne van de Vooren.   

Abstract

Mesh：

Year:  2011        PMID： 21874376     DOI： 10.1007/s10198-011-0348-5

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  10 in total

1.  Proposal of Polish guidelines for conducting financial analysis and their comparison to existing guidance on budget impact in other countries.

Authors:  Ewa Orlewska; Piotr Mierzejewski
Journal:  Value Health       Date:  2004 Jan-Feb       Impact factor: 5.725

2.  A proposal for Italian guidelines in pharmacoeconomics The Mario Negri Institute Centre for Health Economics.

Authors:  L Garattini; R Grilli; D Scopelliti; L Mantovani
Journal:  Pharmacoeconomics       Date:  1995-01       Impact factor: 4.981

3.  Current trends in the use of pharmacoeconomics and outcomes research in europe.

Authors:  M Drummond; D Dubois; L Garattini; B Horisberger; B Jönsson; I S Kristiansen; C Le Pen; C G Pinto; P B Poulsen; J Rovira; F Rutten; M G von der Schulenburg; H Sintonen
Journal:  Value Health       Date:  1999 Sep-Oct       Impact factor: 5.725

4.  Principles of good practice for budget impact analysis: report of the ISPOR Task Force on good research practices--budget impact analysis.

Authors:  Josephine A Mauskopf; Sean D Sullivan; Lieven Annemans; Jaime Caro; C Daniel Mullins; Mark Nuijten; Ewa Orlewska; John Watkins; Paul Trueman
Journal:  Value Health       Date:  2007 Sep-Oct       Impact factor: 5.725

Review 5.  Guidelines for conducting pharmaceutical budget impact analyses for submission to public drug plans in Canada.

Authors:  Deborah A Marshall; Patrick R Douglas; Michael F Drummond; George W Torrance; Stuart Macleod; Orlando Manti; Lokanadha Cheruvu; Ron Corvari
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

Review 6.  Economic evaluations in the EURONHEED: a comparative analysis.

Authors:  Florencia Hutter; Fernando Antoñanzas
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 7.  Budget-impact analyses: a critical review of published studies.

Authors:  Ewa Orlewska; Laszlo Gulácsi
Journal:  Pharmacoeconomics       Date:  2009       Impact factor: 4.981

Review 8.  Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Authors:  M C Weinstein; J E Siegel; M R Gold; M S Kamlet; L B Russell
Journal:  JAMA       Date:  1996-10-16       Impact factor: 56.272

Review 9.  Developing guidance for budget impact analysis.

Authors:  P Trueman; M Drummond; J Hutton
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

Review 10.  Practical issues in handling data input and uncertainty in a budget impact analysis.

Authors:  M J C Nuijten; T Mittendorf; U Persson
Journal:  Eur J Health Econ       Date:  2010-04-03
  10 in total
  22 in total

Review 1.  Cost-Effectiveness Modeling in Multiple Sclerosis: Playing Around with Non-Healthcare Costs?

Authors:  Livio Garattini; Francesca Ghislandi; Milene Rangel Da Costa
Journal:  Pharmacoeconomics       Date:  2015-12       Impact factor: 4.981

2.  Dutch guidelines for economic evaluation: 'from good to better' in theory but further away from pharmaceuticals in practice?

Authors:  Livio Garattini; Anna Padula
Journal:  J R Soc Med       Date:  2017-01-24       Impact factor: 5.344

3.  Sustainability of behavioral interventions: beyond cost-effectiveness analysis.

Authors:  Paul M Brown; Linda D Cameron; Steven Ramondt
Journal:  Int J Behav Med       Date:  2015-06

Review 4.  The French National Authority for Health (HAS) Guidelines for Conducting Budget Impact Analyses (BIA).

Authors:  Salah Ghabri; Erwan Autin; Anne-Isabelle Poullié; Jean Michel Josselin
Journal:  Pharmacoeconomics       Date:  2018-04       Impact factor: 4.981

5.  Budget impact analysis of vaccination against Haemophilus influenzae type b as a part of a Pentavalent vaccine in the childhood immunization schedule of Iran.

Authors:  Fatemeh Teimouri; Abbas Kebriaeezadeh; Seyed Mohsen Zahraei; MohammadMahdi Gheiratian; Shekoufeh Nikfar
Journal:  Daru       Date:  2017-01-14       Impact factor: 3.117

6.  Improving and sustaining delivery of CPT for PTSD in mental health systems: a cluster randomized trial.

Authors:  Shannon Wiltsey Stirman; Erin P Finley; Norman Shields; Joan Cook; Rachel Haine-Schlagel; James F Burgess; Linda Dimeff; Kelly Koerner; Michael Suvak; Cassidy A Gutner; David Gagnon; Tasoula Masina; Matthew Beristianos; Kera Mallard; Vanessa Ramirez; Candice Monson
Journal:  Implement Sci       Date:  2017-03-06       Impact factor: 7.327

7.  Improving Maternal Care through a State-Wide Health Insurance Program: A Cost and Cost-Effectiveness Study in Rural Nigeria.

Authors:  Gabriela B Gomez; Nicola Foster; Daniella Brals; Heleen E Nelissen; Oladimeji A Bolarinwa; Marleen E Hendriks; Alexander C Boers; Diederik van Eck; Nicole Rosendaal; Peju Adenusi; Kayode Agbede; Tanimola M Akande; Michael Boele van Hensbroek; Ferdinand W Wit; Catherine A Hankins; Constance Schultsz
Journal:  PLoS One       Date:  2015-09-28       Impact factor: 3.240

8.  Routine HIV screening in Portugal: clinical impact and cost-effectiveness.

Authors:  Yazdan Yazdanpanah; Julian Perelman; Madeline A DiLorenzo; Joana Alves; Henrique Barros; Céu Mateus; João Pereira; Kamal Mansinho; Marion Robine; Ji-Eun Park; Eric L Ross; Elena Losina; Rochelle P Walensky; Farzad Noubary; Kenneth A Freedberg; A David Paltiel
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

9.  Early treatment versus expectative management of patent ductus arteriosus in preterm infants: a multicentre, randomised, non-inferiority trial in Europe (BeNeDuctus trial).

Authors:  Tim Hundscheid; Wes Onland; Bart van Overmeire; Peter Dijk; Anton H L C van Kaam; Koen P Dijkman; Elisabeth M W Kooi; Eduardo Villamor; André A Kroon; Remco Visser; Daniel C Vijlbrief; Susanne M de Tollenaer; Filip Cools; David van Laere; Anne-Britt Johansson; Catheline Hocq; Alexandra Zecic; Eddy Adang; Rogier Donders; Willem de Vries; Arno F J van Heijst; Willem P de Boode
Journal:  BMC Pediatr       Date:  2018-08-04       Impact factor: 2.125

10.  Capturing Budget Impact Considerations Within Economic Evaluations: A Systematic Review of Economic Evaluations of Rotavirus Vaccine in Low- and Middle-Income Countries and a Proposed Assessment Framework.

Authors:  Natalie Carvalho; Mark Jit; Sarah Cox; Joanne Yoong; Raymond C W Hutubessy
Journal:  Pharmacoeconomics       Date:  2018-01       Impact factor: 4.981
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.